Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00696111 · ClinicalTrials.gov registry record · NA

Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea

A NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT00696111: Completed NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, sponsored by University of Chicago.

NCT00696111 is a NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome that has completed, run by University of Chicago. The registered enrollment target is 18 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00696111, a NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at the metabolic (use of energy) and hormonal features of sleep problems in women with polycystic ovary syndrome (PCOS).

Primary Outcome

Estrogen levels measured every 20 minutes for 24 hours and the the average of those values are presented. The units of measurement are picograms per milliter (pg/ml).

Interventions

  • DRUG Depot Lupron followed by estrogen plus placebo

Study Locations (1)

Illinois

  • University of Chicago Department of Medicine, Section of Endocrinology, Diabetes & Metabolism - Chicago

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2007-12
Est. Completion 2022-06-30
Phase NA
University of Chicago

796 total trials

What the finished NCT00696111 record still lists

NCT00696111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Depot Lupron followed by estrogen plus placebo is the first listed.

NCT00696111 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00696111 about?

NCT00696111 is a clinical study titled "Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea". The purpose of this study is to look at the metabolic (use of energy) and hormonal features of sleep problems in women with polycystic ovary syndrome (PCOS).

What is the current status of trial NCT00696111?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2007-12. Estimated completion is 2022-06-30.

What conditions does trial NCT00696111 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Polycystic Ovary Syndrome.

What interventions are being tested in trial NCT00696111?

The interventions under investigation include: Depot Lupron followed by estrogen plus placebo (DRUG).

Who is sponsoring clinical trial NCT00696111?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00696111 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00696111's enrollment target sits among peer trials

18 144th of 155 higher than 9 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00696111, the US trial registry maintained by the National Library of Medicine. NCT00696111 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.